The weekly litigation news digest is live. Subscribe now

IP Verse

Long Germline Dh Genes And Long Hcdr3 Antibodies - EP3476942

The patent EP3476942 was granted to Trianni on Jan 26, 2022. The application was originally filed on Oct 27, 2017 under application number EP17198800A. The patent is currently recorded with a legal status of "Revoked".

EP3476942

TRIANNI
Application Number
EP17198800A
Filing Date
Oct 27, 2017
Status
Revoked
Mar 14, 2025
Publication Date
Jan 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSOct 25, 2022J A KEMPADMISSIBLE

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2013219535
DESCRIPTIONUS5591669
DESCRIPTIONUS5593598
DESCRIPTIONUS5612205
DESCRIPTIONUS5661016
DESCRIPTIONUS5789650
DESCRIPTIONUS5814318
DESCRIPTIONUS5874299
DESCRIPTIONUS5877397
DESCRIPTIONUS6023010
DESCRIPTIONUS6091001
DESCRIPTIONUS6130364
DESCRIPTIONUS6162963
DESCRIPTIONUS6570061
DESCRIPTIONUS6596541
DESCRIPTIONUS6673986
DESCRIPTIONUS7041871
DESCRIPTIONUS7064244
DESCRIPTIONUS7145056
DESCRIPTIONWO2017035252
EXAMINATIONWO2011158009
EXAMINATIONWO2013041844
OPPOSITIONUS2013219535
OPPOSITIONWO2011158009
OPPOSITIONWO2021003152
OTHERUS2013219535
OTHERWO2011158009

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents